Targeting Cognition in Bipolar Disorder With Pramipexole

PHASE4CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

July 26, 2018

Study Completion Date

July 26, 2018

Conditions
Bipolar Disorder
Interventions
DRUG

Pramipexole

Up to 4.5mg, PO, (by mouth) per day of the 12-week study.

DRUG

Placebo

placebo match study drug

Trial Locations (3)

10029

Icahn School of Medicine at Mount Sinai, New York

11004

The Zucker Hillside Hospital, Glen Oaks

02115

Brigham and Women's Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

The Zucker Hillside Hospital

OTHER

collaborator

Northwell Health

OTHER

collaborator

National Institute of Mental Health (NIMH)

NIH

collaborator

Icahn School of Medicine at Mount Sinai

OTHER

lead

Brigham and Women's Hospital

OTHER